Carregant...
Adjuvant and Neoadjuvant Imatinib Therapy: Current Role in the Management of GIST
Although surgery remains the mainstay for the treatment of primary gastrointestinal stromal tumors (GIST), a significant number of patients experience disease recurrence within 5 years of surgery. The emergence of imatinib therapy for the treatment of patients with advanced GIST has offered unpreced...
Guardat en:
| Publicat a: | Int J Cancer |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7596877/ https://ncbi.nlm.nih.gov/pubmed/21671474 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.26234 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|